Drug Shortage Report for APRI 28
| Report ID | 10871 |
| Drug Identification Number | 02317206 |
| Brand name | APRI 28 |
| Common or Proper name | DESOGESTREL ETHINYL ESTRADIOL |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DESOGESTREL ETHINYL ESTRADIOL |
| Strength(s) | 0.15MG 0.03MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 6 |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2017-05-15 |
| Estimated end date | 2017-08-04 |
| Actual end date | 2017-09-15 |
| Shortage status | Resolved |
| Updated date | 2017-09-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-09-19 | French | Compare |
| v3 | 2017-09-19 | English | Compare |
| v2 | 2017-05-23 | French | Compare |
| v1 | 2017-05-23 | English | Compare |
Showing 1 to 4 of 4